Capstone therapeutics corp. CAPS.US AI Analysis
BetaUS StockHealthcare
(No presentation for CAPS)
CAPS Value Score
3
24
15
Limited Growth
Analysis Conclusion
The stock has a lower value rating; if aiming for value investing, existing long-term positions might require gradual reduction.
CAPS Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of CAPS from 2007-01-01 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to July, 2025. (Total Trades: 0)
| CAPS | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 48% | 58% |
| Avg Return | - | 46.7% | 61.1% |
| Avg Profit | - | 141.7% | 128% |
| Avg Loss | - | -40.2% | -32.2% |
| Avg Risk-Reward Ratio | - | 352.4% | 398.1% |